We recently discovered an inherited cancer syndrome caused by BRCA1-Associated Protein 1 (BAP1) germline mutations, with high incidence of mesothelioma, uveal melanoma and other cancers and very high penetrance by age 55. To identify families with the BAP1 cancer syndrome, we screened patients with family histories of multiple mesotheliomas and melanomas and/or multiple cancers. We identified four families that shared an identical BAP1 mutation: they lived across the US and did not appear to be related. By combining family histories, molecular genetics, and genealogical approaches, we uncovered a BAP1 cancer syndrome kindred of ~80,000 descendants with a core of 106 individuals, whose members descend from a couple born in Germany in the early 1700s who immigrated to North America. Their descendants spread throughout the country with mutation carriers affected by multiple malignancies. Our data show that, once a proband is identified, extended analyses of these kindreds, using genomic and genealogical studies to identify the most recent common ancestor, allow investigators to uncover additional branches of the family that may carry BAP1 mutations. Using this knowledge, we have identified new branches of this family carrying BAP1 mutations. We have also implemented early-detection strategies that help identify cancers at early-stage, when they can be cured (melanomas) or are more susceptible to therapy (MM and other malignancies).
References
[1]
Baumann F, Ambrosi JP, Carbone M. Asbestos is not just asbestos: an unrecognised health hazard. The Lancet Oncology. 2013;14(7):576–8. Epub 2013/06/04. doi: 10.1016/S1470-2045(13)70257-2. pmid:23725699
[2]
Roushdy-Hammady I, Siegel J, Emri S, Testa JR, Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet. 2001;357(9254):444–5. Epub 2001/03/29. pmid:11273069 doi: 10.1016/s0140-6736(00)04013-7
[3]
Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet. 2011;43(10):1022–5. Epub 2011/08/30. doi: 10.1038/ng.912. pmid:21874000
[4]
Abdel-Rahman MH, Pilarski R, Cebulla CM, Massengill JB, Christopher BN, Boru G, et al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. Journal of medical genetics. 2011;48(12):856–9. doi: 10.1136/jmedgenet-2011-100156. pmid:21941004
[5]
Pena-Llopis S, Vega-Rubin-de-Celis S, Liao A, Leng N, Pavia-Jimenez A, Wang S, et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet. 2012;44(7):751–9. doi: 10.1038/ng.2323. pmid:22683710
[6]
de la Fouchardiere A, Cabaret O, Savin L, Combemale P, Schvartz H, Penet C, et al. Germline BAP1 mutations predispose also to multiple basal cell carcinomas. Clinical genetics. 2014. doi: 10.1111/cge.12472
[7]
Carbone M, Korb Ferris L, Baumann F, Napolitano A, Lum CA, Flores EG, et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med. 2012;10(1):179. Epub 2012/09/01. doi: 10.1186/1479-5876-10-179
[8]
Piris A, Mihm MC Jr., Hoang MP. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations. Human pathology. 2015;46(2):239–45. doi: 10.1016/j.humpath.2014.10.015. pmid:25479927
[9]
Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G. BAP1 and cancer. Nat Rev Cancer. 2013;13(3):153–9. Epub 2013/04/04. pmid:23550303 doi: 10.1038/nrc3459
[10]
Cybulski C, Nazarali S, Narod SA. Multiple primary cancers as a guide to heritability. International journal of cancer Journal international du cancer. 2014;135(8):1756–63. doi: 10.1002/ijc.28988. pmid:24945890
[11]
Lee HS, Lee SA, Hur SK, Seo JW, Kwon J. Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis. Nature communications. 2014;5:5128. doi: 10.1038/ncomms6128. pmid:25283999
[12]
Yu H, Pak H, Hammond-Martel I, Ghram M, Rodrigue A, Daou S, et al. Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(1):285–90. doi: 10.1073/pnas.1309085110. pmid:24347639
[13]
Yu H, Mashtalir N, Daou S, Hammond-Martel I, Ross J, Sui G, et al. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Molecular and cellular biology. 2010;30(21):5071–85. doi: 10.1128/MCB.00396-10. pmid:20805357
[14]
Eletr ZM, Wilkinson KD. An emerging model for BAP1's role in regulating cell cycle progression. Cell biochemistry and biophysics. 2011;60(1–2):3–11. doi: 10.1007/s12013-011-9184-6. pmid:21484256
[15]
Scheuermann JC, de Ayala Alonso AG, Oktaba K, Ly-Hartig N, McGinty RK, Fraterman S, et al. Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature. 2010;465(7295):243–7. doi: 10.1038/nature08966. pmid:20436459
[16]
Ismail IH, Davidson R, Gagne JP, Xu ZZ, Poirier GG, Hendzel MJ. Germline mutations in BAP1 impair its function in DNA double-strand break repair. Cancer research. 2014;74(16):4282–94. doi: 10.1158/0008-5472.CAN-13-3109. pmid:24894717
[17]
Ventii KH, Devi NS, Friedrich KL, Chernova TA, Tighiouart M, Van Meir EG, et al. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer research. 2008;68(17):6953–62. doi: 10.1158/0008-5472.CAN-08-0365. pmid:18757409
[18]
Baumann F, Flores E, Napolitano A, Kanodia S, Taioli E, Pass H, et al. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 2015;36(1):76–81. doi: 10.1093/carcin/bgu227. pmid:25380601
[19]
Genomes Project C, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422):56–65. doi: 10.1038/nature11632. pmid:23128226
[20]
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904–9. pmid:16862161 doi: 10.1038/ng1847
[21]
Voight BF, Pritchard JK. Confounding from cryptic relatedness in case-control association studies. PLoS genetics. 2005;1(3):e32. pmid:16151517 doi: 10.1371/journal.pgen.0010032.eor
[22]
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. American journal of human genetics. 2007;81(3):559–75. pmid:17701901 doi: 10.1086/519795
[23]
Zheng X, Levine D, Shen J, Gogarten SM, Laurie C, Weir BS. A high-performance computing toolset for relatedness and principal component analysis of SNP data. Bioinformatics. 2012;28(24):3326–8. doi: 10.1093/bioinformatics/bts606. pmid:23060615
[24]
Delaneau O, Howie B, Cox AJ, Zagury JF, Marchini J. Haplotype estimation using sequencing reads. American journal of human genetics. 2013;93(4):687–96. doi: 10.1016/j.ajhg.2013.09.002. pmid:24094745
[25]
Browning BL, Browning SR. Detecting identity by descent and estimating genotype error rates in sequence data. American journal of human genetics. 2013;93(5):840–51. doi: 10.1016/j.ajhg.2013.09.014. pmid:24207118
[26]
Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, et al. High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 2015;10(4):565–76. doi: 10.1097/jto.0000000000000471
[27]
Rusch A, Ziltener G, Nackaerts K, Weder W, Stahel RA, Felley-Bosco E. Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases. Lung cancer. 2015;87(1):77–9. doi: 10.1016/j.lungcan.2014.10.017. pmid:25468148
[28]
Carbone M, Klein G, Gruber J, Wong M. Modern criteria to establish human cancer etiology. Cancer research. 2004;64(15):5518–24. pmid:15289363 doi: 10.1158/0008-5472.can-04-0255
[29]
Napolitano A, Pellegrini L, Dey A, Larson D, Tanji M, Flores EG, et al. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene. 2015. doi: 10.1038/onc.2015.243
[30]
Cebulla CM, Binkley EM, Pilarski R, Massengill JB, Rai K, Liebner DA, et al. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients. Ophthalmic genetics. 2015;36(2):126–31. doi: 10.3109/13816810.2015.1010734. pmid:25687217